Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Opus Genetics, Inc. | Chief Executive Officer | Common Stock | 493K | $505K | $1.02 | Nov 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRD | Opus Genetics, Inc. | Nov 15, 2024 | 2 | $101K | 4 | Nov 19, 2024 | Chief Executive Officer |
IRD | Opus Genetics, Inc. | Nov 1, 2024 | 1 | -$43.7K | 4 | Nov 5, 2024 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | May 17, 2024 | 1 | $8.77K | 4 | May 21, 2024 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | Mar 18, 2024 | 1 | $49.1K | 4 | Mar 20, 2024 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | Nov 1, 2023 | 2 | $0 | 4 | Nov 3, 2023 | Chief Executive Officer |
OCUP | Ocuphire Pharma, Inc. | Nov 1, 2023 | 0 | $0 | 3 | Nov 3, 2023 | Chief Executive Officer |